Anti-inflammatory therapies in TRAMP mice: delay in PCa progression

作者: Larissa Akemi Kido , Fabio Montico , Rafael Sauce , Aline Barbosa Macedo , Elaine Minatel

DOI: 10.1530/ERC-15-0540

关键词: TrampProstateCancerIntraepithelial neoplasiaImmunohistochemistryAdenocarcinomaCelecoxibCancer researchProstate cancerMedicine

摘要: The aim of this study was to characterize the structural and molecular biology as well evaluate immediate late responses prostatic cancer in transgenic adenocarcinoma mouse prostate (TRAMP) model after treatment with goniothalamin (GTN) celecoxib. treated mice received GTN (150 mg/kg, gavage) or celecoxib (10 from 8 12 weeks age. They were killed at different ages: immediate-response groups late-response 22 weeks. ventral collected for light microscopy, immunohistochemistry, western blotting, TUNEL, ELISA. Morphological analyses indicated that delayed progression adenocarcinoma, leading a significant decrease lesion frequency both experimental period treatment, mainly high-grade intraepithelial neoplasia well-differentiated adenocarcinoma. Also, showed particular proliferative processes (PCNA) periods. Despite diminishing COX2 IGFR1 levels, presented higher action spectrum considering greater number involved inflammatory cancer. Goniothalamin attenuated pro-inflammatory response TRAMP microenvironment, delaying (PCa) progression. Celecoxib efficient regulation mice, advanced disease grade. Finally, we concluded process control early grades PCa crucial downregulation signaling pathways grades.

参考文章(57)
Rainy Umbas, Chaidir A Mochtar, Agus Rizal A H Hamid, Recent role of inflammation in prostate diseases: chemoprevention development opportunity. Acta medica Indonesiana. ,vol. 43, pp. 59- 65 ,(2011)
Weibel Er, Principles and methods for the morphometric study of the lung and other organs. Laboratory Investigation. ,vol. 12, pp. 131- 155 ,(1963)
Y. Hakeda, S. Harada, T. Matsumoto, K. Tezuka, K. Higashino, H. Kodama, T. Hashimoto-Goto, E. Ogata, M. Kumegawa, Prostaglandin F2 alpha stimulates proliferation of clonal osteoblastic MC3T3-E1 cells by up-regulation of insulin-like growth factor I receptors. Journal of Biological Chemistry. ,vol. 266, pp. 21044- 21050 ,(1991) , 10.1016/S0021-9258(18)54818-3
Thomas Boehm, Judah Folkman, Timothy Browder, Michael S. O'Reilly, Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature. ,vol. 390, pp. 404- 407 ,(1997) , 10.1038/37126
Jennifer A Tuxhorn, Truong D Dang, Megan J Smith, David R Rowley, Vincent C Smith, Gustavo E Ayala, Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling Clinical Cancer Research. ,vol. 8, pp. 2912- 2923 ,(2002)
Nicholas A Daniels, Yea-Hung Chen, Stephen Bent, Antibiotic and anti-inflammatory use and the risk of prostate cancer BMC Research Notes. ,vol. 2, pp. 57- 57 ,(2009) , 10.1186/1756-0500-2-57
Barbora Orlikova, Marc Schumacher, Tom Juncker, Choo Chee Yan, Salmaan H. Inayat-Hussain, Shéhérazade Hajjouli, Claudia Cerella, Mario Dicato, Marc Diederich, Styryl-lactone goniothalamin inhibits TNF-α-induced NF-κB activation Food and Chemical Toxicology. ,vol. 59, pp. 572- 578 ,(2013) , 10.1016/J.FCT.2013.06.051
Bob Djavan, Elisabeth Eckersberger, Geovanni Espinosa, Gero Kramer, Alessandra Handisurya, Chung Lee, Michael Marberger, Herbert Lepor, Georg E. Steiner, Complex Mechanisms in Prostatic Inflammatory Response European Urology Supplements. ,vol. 8, pp. 872- 878 ,(2009) , 10.1016/J.EURSUP.2009.11.003